Headlines

Go To Pro Hockey Rumors
Go To Hoops Rumors

Anthony Volpe

Poll: Will Anthony Volpe Be The Yankees’ Shortstop In 2026?

By | at

All things considered, it was a solid year for the Yankees even if it didn’t live up to the perennial World-Series-or-bust expectations of their fans. Despite Gerrit Cole not throwing a single pitch for the team this year and Juan Soto signing elsewhere last winter, they managed to win 94 games thanks to a few key additions like Max Fried and Cody Bellinger, big steps forward from Ben Rice and Trent Grisham, and another MVP-caliber campaign from Aaron Judge.

Not everything went right for the Yankees this year, however, and that’s even ignoring the outcome of the postseason. Some young players who looked like key pieces of the organization’s future this time last year took steps backwards in 2025. While that’s true of Austin Wells and Luis Gil, there’s no player who better exemplifies this than shortstop Anthony Volpe. Volpe was once a consensus top-15 prospect in the sport and even won the Gold Glove in his rookie season with the Yankees, but he’s never quite been able to muster even a league average slash line at the plate.

An 87 wRC+ last year was enough to make him a three-to-four win player thanks to his stellar defense. But this season, the wheels came off. The biggest reason for that is the decline of Volpe’s glove. After being one of the best defenders in all of baseball last year with +14 Outs Above Average, he flipped the script entirely and put up one of the worst performances of any defender in the sport with an OAA of -7.

That’s the sort of defense that might not cut it for a strong bat at the infield’s most important defensive position, so it certainly wasn’t cutting it while Volpe hit a paltry .212/.272/.391 (83 wRC+) in 153 games this year. Some of that can be attributed to poor fortune on batted balls, as his BABIP dropped 50 points relative to the year prior despite a career-high barrel rate of 10.5%. That’s not the whole story, however, as he also hit the fewest line drives of his career this year (15.4%) and struck out at an elevated 25.2% clip. Even his baserunning took a step back, as he went just 18-for-26 on the basepaths after stealing 28 bases in 35 last year.

It’s possible that a partial labrum tear that Volpe spent most of the season playing through is to blame for at least some of his struggles this season. He had a .237/.328/.456 slash and 119 wRC+ through the end of April, just a few days before injuring his shoulder. He hit .205/.255/.374 for a 74 wRC+ from the start of May onwards. He underwent surgery to repair that shoulder but will start 2026 on the injured list.

That might make it seem obvious that the Yankees should either move on from Volpe entirely or at least bring in a player who can handle the majority of shortstop duties while Volpe slips into a smaller role. Things aren’t likely to be that simple, however, in large part due to the weakness of the coming class of shortstops. The prize of this class is Bo Bichette, but he comes with defensive concerns of his own and has long been viewed as a player who would profile better at either second or third base.

The pickings are quite slim outside of Bichette when it comes to shortstops, however. Ha-Seong Kim might opt out of his contract with Atlanta, but he’s coming off an even more difficult season than Volpe. Trevor Story might be a modest upgrade, but he offers limited upside headed into his age-33 season and might not opt out of his contract with the Red Sox. The trade market might feature CJ Abrams but his defense is questionable enough that he may not stick at that spot for much longer. Without another replacement who would be a clear upgrade over Volpe, the Yankees may be forced to choose between either shelling out for a defensively-flawed solution in Bichette or sticking with their internal options.

Those internal options don’t necessarily have to lead to Volpe starting the majority of the Yankees’ games at shortstop next year, though that might be the most likely outcome. Jose Caballero will be back next season and earned plenty of fans in the Bronx for his work on both sides of the ball in 40 games down the stretch. Perhaps he could share time with Volpe at shortstop in the early part of 2026, with the possibility of top-100 prospect George Lombard Jr. stepping up later in the season. Lombard spent most of 2025 at Double-A, so a debut in 2026 isn’t entirely unrealistic. However, he also hit just .215/.337/.358 at the level, suggesting he might need more time to develop before arriving in the show.

How do MLBTR readers view New York’s shortstop situation? Will Volpe be the solution at the position next year? Will they bring in a free agent or trade for someone to handle things? Or will an internal candidate like Caballero or Lombard take the job from Volpe by the end of next year? Have your say in the poll below:

Aaron Judge Will Not Require Elbow Surgery; Rodón, Volpe Expected To Start 2026 On IL

By | at

Yankees manager Aaron Boone held a press conference today and provided some notable updates about players on the roster. Outfielder Aaron Judge will not require offseason surgery on his right elbow. However, left-hander Carlos Rodón underwent a procedure to remove loose bodies from his left elbow. He will be no-throw for eight weeks and will likely miss the start of next season. Shortstop Anthony Volpe, who had shoulder surgery this week, won’t be able to hit for four months and won’t be able to dive for six months. Chris Kirschner of The Athletic was among those to relay the updates (tweet one, two and three). General manager Brian Cashman also confirmed, per Greg Joyce of The New York Post, that Volpe will indeed start the season on the injured list.

The news on Judge is obviously good. He was diagnosed with a flexor strain in July. Though his stint on the IL was minimal, he was limited to designated hitter duties in August. This was a bit awkward, as it forced Giancarlo Stanton into the field, surely more than the Yankees had planned on. Judge gradually played the outfield more throughout September and into October.

If Judge had required Tommy John surgery or some other significant elbow operation, that would have had lingering impacts into the 2026 season, though it seems Judge will be expected to be a full-time outfielder again next year. That should allow the Yankees to go into 2026 planning on having Judge in right and Stanton in the DH slot.

The outfield will still be a focus this offseason, however. Trent Grisham is an impending free agent. Cody Bellinger is going to opt out of his contract and hit the open market as well. That leaves Judge and Jasson Domínguez as the two outfield holdovers. A former top prospect, Domínguez has yet to fully break out. 2025 was his largest stretch of big league playing time. He produced roughly league average offense with poor defense.

Per Kirschner, Boone expects Domínguez to be a regular with the Yanks next year but the skipper added the caveat that it depends what moves happen this offseason. The Yanks could pursue reunions with Bellinger and/or Grisham while the free agent market also features names like Kyle Tucker, Harrison Bader and Cedric Mullins. The trade market should feature names like Lars Nootbaar, Alec Burleson, Adolis García and others. Per Jack Curry of the YES Network, Cashman said he would love to have Bellinger back but the Yankees haven’t had any offseason discussions yet. Per Kirschner, Cashman says that prospect Spencer Jones has also put himself in the mix for a job next year, though that also depends on what happens in the offseason.

The Rodón news is obviously less pleasant. It doesn’t appear as though he’s slated for a huge absence, but the Yanks will go into the season with a few guys on the IL. Gerrit Cole had Tommy John surgery in March of last year. He should return at some point in 2026 but Boone confirmed today, per Kirschner, that Cole would not be ready by Opening Day. Clarke Schmidt had his own TJS in July and will be out well into the 2026 campaign.

Those arms could provide nice in-season boosts to the rotation but the Yanks will have to begin the campaign without them. As of right now, the Opening Day rotation projects as Max Fried, Luis Gil, Cam Schlittler and Will Warren. The Yankees will presumably look to bolster that before Opening Day. It’s possible they end up with a crowded group once Rodón and Cole get back on the mound but other injuries are fairly inevitable. The free agent market is headlined by guys like Framber Valdez, Tatsuya Imai, Dylan Cease and Ranger Suárez, while the trade market could feature MacKenzie Gore, Joe Ryan and plenty others.

As for Volpe, it seems Boone still views him as the shortstop once he’s healthy. “Yeah, he’s right in the mix to do that,” Boone said today, per Kirschner. Cashman also admitted today, per Bryan Hoch of MLB.com, that the shoulder issue was impacting Volpe during the season.

That’s backed up by the numbers. Volpe’s defensive metrics dropped significantly this year. He had six Defensive Runs Saved and 14 Outs Above Average in 2024 but 2 DRS and -7 OAA in 2025. His offense finished in a similar spot to previous seasons but he seemed to drop off a cliff once he suffered the injury. He had a .237/.328/.456 slash and 119 wRC+ through the end of April, just a few days before injuring his shoulder. He hit .205/.255/.374 for a 74 wRC+ from the start of May onwards.

Going into 2026, the Yankees could look to external options, though there aren’t surefire answers out there. The free agent market is headlined by Bo Bichette, who is an excellent hitter but a poor defender. Guys like Ha-Seong Kim and Trevor Story could be out there via opt-outs, though there are issues there as well. Kim is coming off a poor season after recovering from shoulder surgery. Story had a bounceback year after his own injury odyssey but he’s about to turn 33 and may not opt out anyway. CJ Abrams may be available in trade but he’s not a great defender either and the bat is inconsistent.

Perhaps the Yankees will let José Caballero hold the job until Volpe is healthy. Caballero played well after being acquired at the deadline. Braden Shewmake is on the roster as depth and the Yanks could bring in some veteran utility types.

Photo courtesy of Brett Davis, Imagn Images

Anthony Volpe Undergoes Shoulder Surgery

By | at

Anthony Volpe spent much of the 2025 season playing through a partially torn left labrum, and the Yankees shortstop addressed the problem in the form of a surgical procedure yesterday, according to Joel Sherman and Greg Joyce of the New York Post.  The exact timeline for Volpe’s recovery isn’t yet clear, but if everything goes normally, a source tells Sherman/Joyce that Volpe would be ready for the start of the 2026 season.

The injury to Volpe’s non-throwing shoulder occurred in early May, when Volpe said he heard “a pop” in his shoulder after diving to try and snag a grounder.  What seemed like a minor issue at the time ended up being a lingering source of discomfort throughout the season, and Volpe received two cortisone shots (one at the All-Star break, one in September) to try and manage the pain.  The Yankees never placed Volpe on the injured list, but he didn’t play for the week following his second shot in September.

It is impossible to think that the injury didn’t contribute to Volpe’s tough season.  He hit .212/.272/.391 with 19 home runs over 596 plate appearances, resulting in just an 83 wRC+.  While these numbers weren’t far off what Volpe produced when healthy in 2023-24, it is worth noting that April (prior to the shoulder issue) was far and away Volpe’s best offensive month of 2025.  The bigger impact may have come defensively, as Volpe dropped to -7 Outs Above Average and +2 Defensive Runs Saved — middling metrics for a shortstop who was a Gold Glove winner in 2023 and a finalist for the award again in 2024.

Volpe’s struggles made him a particular target for fan criticism in the Bronx, and something of an avatar for the fanbase’s frustrations towards GM Brian Cashman and manager Aaron Boone.  There has yet to be any sign that Volpe’s starting job might be in danger, though Jose Caballero provided a big spark to the lineup after being acquired at the trade deadline, and getting a good dose of time at shortstop while Volpe was sidelined in September.

More will be known about Volpe’s recovery process in the coming weeks, but if he has any kind of setback, the Yankees could be encouraged to pursue at least a depth option at shortstop this winter if Caballero isn’t entrusted with the starting job.  There will certainly be more speculation about whether or not the Yankees could land a bigger-name shortstop in a larger shake-up for the position, but it doesn’t feel like the Yankees would be inclined to move on entirely from Volpe, due to his former top-prospect status and the team’s three remaining years of control over his services.  Volpe is arbitration-eligible for the first time this winter, and projected to earn $3.9MM in 2026.

Yankees Notes: Judge, Bellinger, Volpe

By | at

Aaron Judge’s massive postseason performance made it easy to forget he’s been dealing with a flexor strain in his right elbow since July. The slugger had multiple hits in all but one game across the first two rounds of the playoffs. Judge engineered a defining postseason moment in Game 3 against Toronto, smashing a game-tying homer off Louis Varland.

With the Yankees now headed into the offseason, Judge was asked about the plan for his ailing elbow. “We’ll definitely do some work on it and get it right,” Judge told reporters, including Chris Kirschner of The Athletic. When asked about surgery specifically, Judge remained noncommittal. “I’m not a doctor. I don’t know.”

The flexor strain forced Judge to the IL in late July. It was a minimum stint on the IL, but he was unable to play the field upon returning. Judge spent all of August at DH. He made it back to his familiar home in right field on September 5. Judge bounced between right field and DH for the final month of the season. In the playoffs, he played exclusively in the field, with Giancarlo Stanton manning the DH spot in all seven games.

Initial tests did not reveal any ulnar collateral ligament damage for Judge. His recovery from surgery to address the flexor strain, if he were to go that route, would not be as long as for a more serious elbow injury like a UCL tear.

Anthony Volpe was similarly tight-lipped about offseason surgery for his shoulder injury. “I anticipated playing another month and then reassessing then. So nothing’s [decided] … we’re going to figure it out,” Volpe told reporters, including Bryan Hoch of MLB.com.

Volpe partially tore the labrum in his shoulder back in May. He didn’t go on the IL with the injury, but his performance suffered. Volpe slashed a solid .237/.328/.456 through April. His numbers tumbled to .205/.255/.374 over the final five months of the season. Volpe got off to a strong start in the postseason, going 4-for-11 with a home run in the Wild Card round against Boston. He collapsed in the ALDS, managing just one hit in 15 at-bats. Volpe struck out 11 times in the four games against Toronto.

Depending on the severity of the tear, Volpe could elect surgery and still be ready for the 2026 season. Shohei Ohtani tore the labrum in his non-throwing shoulder during the World Series in 2024. He made it back in time for spring training this year.

While Volpe never hit the IL with the shoulder issue, he did miss time in mid-September after receiving a cortisone injection. Midseason acquisition Jose Caballero started six straight games at shortstop from September 10-15. Caballero receded to a bench role once Volpe was deemed healthy, but he did endear himself to Yankees fans with a walk-off single to clinch a postseason bid in the final week of the season. Caballero is under team control through 2029 and could factor into New York’s middle infield plans depending on the health of Volpe.

No matter what Judge and Volpe decide on the surgery front, they’ll definitely be back with the team next season. The same can’t be said for Cody Bellinger, who is facing a decision of his own. Bellinger can opt out of the final year of his current contract with the Yankees. He’d be leaving $20MM on the table ($25MM salary next year but with a $5MM buyout) in pursuit of a longer, potentially more lucrative deal in free agency.

Hoch passed along comments from Bellinger about the pending opt-out decision. As has been the theme with these Yankees, Bellinger didn’t say much. “Obviously, things to discuss with family and the agent and the business side of it all. But tonight, I’m just going to soak it all in and just be a part of the group one more time.”

Bellinger signed his current three-year, $80MM contract with the Cubs ahead of the 2024 season. He could’ve opted out of the deal this past offseason, but declined. Bellinger was then dealt to the Yankees. He slugged 29 home runs in his first year in pinstripes, his most since his 2019 NL MVP season. Bellinger also stayed healthy, topping 600 plate appearances for just the third time in his career. He’s widely expected to opt out of the final year of his deal.

Cashman: Yankees “Believe In” Anthony Volpe Despite “Tough Stretch”

By | at

Anthony Volpe’s underwhelming season has made the shortstop a topic of controversy in the Bronx, and more attention was generated this week when it was revealed that Volpe has been playing with a small tear in his left shoulder labrum since May 3.  Trying to play through this shoulder problem has clearly impacted Volpe’s performance — not only has he hit .197/.248/.378 in 418 plate appearances since suffering the injury, Volpe’s formerly excellent defense has drastically fallen off.

Speaking with ESPN’s Jorge Castillo and other reporters on Friday, Yankees GM Brian Cashman noted Volpe’s “tough stretch” and said that “this isn’t the season we expected or he expected.”  That said, Cashman gave a vote of confidence to Volpe, saying that the 2025 season “doesn’t change our viewpoint of what he’s capable of,” and that he is still the Yankees’ choice at shortstop going forward.

“He’s someone that we can count on and we believe in….I think he’s a really talented guy and I think he has a chance to be a positive impact, obviously,” Cashman said.

Volpe was hitting significantly better (.239/.333/.453) in his first 135 plate appearances of the season pre-injury, so it could be that his labrum tear prevented a potential breakout year.  Still, Volpe’s full-season numbers aren’t far off the .228/.288/.373 slash line he posted over 1290 PA in his first two Major League seasons, so it isn’t as if struggles at the plate are a new problem for the 24-year-old.

Outsized expectations have followed Volpe ever since his emergence as one of baseball’s top prospects, and the Yankees’ decision to debut him as their Opening Day shortstop in 2023.  While the team itself has always been quick to downplay the “next Derek Jeter” hype, the Yankees’ immediate installation of Volpe in an everyday role has stood in stark contrast to the club’s more infrequent usage of most other top minor leaguers in recent years.  If anything, Volpe’s critics are sure to argue that Cashman’s continued confidence in Volpe is part of the problem, and that the Yankees should be more open to upgrading at shortstop.

While Cashman has made some rather blunt critiques of other New York players in the past, it only makes sense for the GM to continue his public support of Volpe, and there isn’t any reason to yet suspect that the Yankees aren’t viewing Volpe’s rough year as anything but a by-product of his shoulder injury.  Since Volpe is only entering arbitration eligibility this coming offseason, his three remaining years of pretty inexpensive team control make him an intriguing asset on a team loaded with big salaries and a hefty luxury tax bill.  If Volpe is able to get healthy and break out as, in Cashman’s words, “a quality, above-average regular shortstop in the game,” that’s a major boost for the Yankees on every front.

Still, finding another inexpensive shortstop candidate could change the equation, and one such player may have already been found in Jose Caballero.  Acquired from the Rays at the trade deadline, Caballero has hit .263/.358/.439 in 68 PA in the pinstripes, which far and away represents the best offensive stretch of his three MLB seasons.  The utilityman has also pitched in at both corner outfield slots, second base, and third base, but most of Caballero’s time has come at shortstop in the wake of Volpe’s increased missed time.

Volpe hasn’t played since Tuesday after receiving a cortisone shot in his ailing shoulder, paving the way for Caballero to step into regular shortstop duty.  Boone told Castillo and company that “we’ll see” about who plays shortstop when Volpe is ready to return, which hints that the Yankees could be considering a timeshare at the position.

The longer-term issue of Volpe’s health is also a lingering question.  Cashman said more will be known once Volpe receives more tests, and while the GM “wouldn’t rule…out” an offseason surgery, “as of right now, there’s no surgery recommended.  There’s not even an IL recommended.”  Should Volpe indeed end up going under the knife, he’d very likely miss some time and perhaps an extended amount of the 2026 season, leaving the Yankees in need of another shortstop.

Anthony Volpe Playing Through Partial Labrum Tear

By | at

Anthony Volpe has been the Yankees’ regular shortstop for close to three years now. Lately, he has struggled enough that José Caballero has taken some playing time. It’s possible that health is playing a role in Volpe’s downturn. He injured his left shoulder back in early May. Today, Joel Sherman of The New York Post reports that the shoulder discomfort has lingered since then and Volpe received a cortisone shot in that shoulder yesterday.

Yankees manager Aaron Boone spoke to the media before tonight’s game and provided more details, per Brendan Kuty of The Athletic and Bryan Hoch of MLB.com. Boone confirmed the report of the cortisone shot and said Volpe has a small labrum tear in his shoulder. When the injury was discovered in May, they believed it was an old injury that he could play through. He has since aggravated it multiple times, including on Sunday. He also had a cortisone shot during the All-Star break, per Kuty. The Yanks don’t believe he needs an IL stint now. He will have another MRI after the season.

At the time of that injury, Volpe said he heard a “pop” in his shoulder but quickly felt better. “It happened quick and it was scary, but after that, I felt OK and I felt like I had my strength,” Volpe said at the time. “I’ve never really had anything else pop or dislocate or anything like that, so I have nothing to compare it to.”

Greg Joyce of The New York Post writes that the Yankees have consistently downplayed the shoulder injury even though Volpe is usually wrapped up in ice after most games. Just yesterday, Boone brushed off the problem, per Chris Kirschner of The Athletic.

“I think early on after that, maybe a little bit,” the skipper said, when asked if Volpe’s shoulder has been impacting his performance. “I think it’s something that’s also improved over the course of the year. I feel like, even lately, it’s been in as good of a place as it’s been. I don’t necessarily think that’s the case, but he’s also a very tough kid and a gamer. I don’t think so, but I guess shouldn’t rule it out.”

As noted by Sherman, there’s a stark contrast between Volpe’s pre- and post-injury numbers. On May 4th, he had a .233/.326/.442 batting line. That translated to a 114 wRC+, indicating he was 14% better than league average at that point in the season. Since then, he has a .197/.248/.378 line and 70 wRC+.

It’s also possible that the injury is impacting Volpe defensively. He was credited with 15 Defensive Runs Saved in 2023 and six last year but is at just one here in 2025. Outs Above Average is even more notable. That metric gave Volpe a +1 grade in 2023 and +14 last year but has dropped him all the way to -9 here in 2025. Volpe made eight throwing errors in 2023 and nine last year but already has 13 in 2025, in a smaller sample of playing time.

Despite the declining numbers, Boone has stuck by Volpe. A couple of weeks ago, the skipper said that he still considered Volpe to be the club’s shortstop while Caballero was considered a “10th man” who could bounce around to various positions in a utility capacity.

More recently, it’s possible there’s been a shift. Caballero has started in place of Volpe in two of the past five games. It’s possible the cortisone shot leads to Volpe missing some more time, as players usually require a few days’ rest after receiving such injections.

On the one hand, it’s somewhat encouraging that Volpe’s struggles have a possible explanation. On the other hand, it’s a less than ideal situation at this time of year when every game is meaningful. The Yanks currently hold a Wild Card spot but they are in a tight battle with clubs like the Red Sox, Mariners, Rangers, Guardians, Royals and Rays. The Yanks are also surely hoping to chase down the Blue Jays for the division lead, currently trailing by just three games.

Sending Volpe to the injured list or simply sitting him for a few games could perhaps help his shoulder woes a bit but that would leave the club a bit thinner at shortstop as they play meaningful games. There would also be the risk of Volpe getting rusty after a layoff and not having time to get into a better groove.

For now, it seems Caballero could benefit from a bit more playing time. He has a solid .239/.345/.413 line since being acquired at the deadline but he has a career .226/.313/.335 slash and 89 wRC+. Even if his hitting is subpar, his glovework is good and he’s one of the top base stealers in the majors. If Volpe does require a stint on the IL, the Yanks could perhaps recall Braden Shewmake to serve as a glove-first backup to Caballero.

Photo courtesy of John Jones, Imagn Images

Boone: Yankees Still Consider Volpe Starting Shortstop

By | at

Anthony Volpe is out of the lineup as the Yankees open their series against the Nationals. It’s the second straight game in which José Caballero gets the start at shortstop. New York is giving the scuffling Volpe what amounts to a two-day mental reset. However, manager Aaron Boone made clear this evening that the Yankees aren’t moving the third-year infielder to the bench.

“I view Anthony as our shortstop,” Boone told reporters (including Chris Kirschner of The Athletic). The skipper confirmed that Volpe would be back in the lineup tomorrow and continue playing regularly from that point. He added that the Yanks consider Caballero their “10th man” and will keep bouncing him around the diamond in a utility role (via Bryan Hoch of MLB.com).

Volpe is hitting .208/.274/.400 across 509 plate appearances. He had a productive April but carries a .198/.255/.382 batting line in 96 games since the beginning of May. Volpe has never hit for a high average or reached base at a strong clip. He’s tied with Dansby Swanson for eighth among shortstops with 18 home runs, but he hasn’t been a productive overall hitter. The struggles have magnified over the past six weeks, as he’s batting .171 with a .203 on-base percentage going back to July 1. Among 253 hitters with at least 100 plate appearances in that stretch, only Miami’s Dane Myers has a lower batting average. No one has a worse on-base mark.

The offensive drought is magnified by his uncharacteristic issues on the other side of the ball. Volpe won a Gold Glove as a rookie in 2023; he was a finalist for that honor last year. He trailed only Swanson and Ezequiel Tovar in combined Defensive Runs Saved among shortstops over those two seasons. Statcast’s Outs Above Average had him tied for seventh. Even with the OBP deficiencies, Volpe’s power and plus defense made him a valuable all-around player. The Yankees presumably felt he was on a similar trajectory as Swanson, an eventual everyday shortstop on a World Series team who received a $177MM free agent contract.

Volpe’s defensive grades have tanked this year as well. DRS has him right around average. Statcast has him five runs below par, tying him for fourth worst at the position. Volpe has committed 17 errors, matching his career high with another month to play. Only Elly De La Cruz (19) has been charged with more this season.

Caballero, acquired from the Rays at the deadline, has gotten out to a fantastic start to his Yankee tenure. He’s hitting .286 with more walks than strikeouts in 15 games. Caballero has stolen six bases in seven tries and is up to an MLB-high 40 steals between Tampa Bay and New York. He led the American League with 44 steals last year, though he was also caught a league leading 16 times. Caballero is a plus runner and versatile defender but is unlikely to remain an above-average hitter over a large sample. He owns a .227/.313/.337 batting line in more than 1000 career plate appearances.

There’s no argument that Caballero hasn’t been the more productive player of late. Still, the 24-year-old Volpe entered the season as New York’s expected franchise shortstop. Caballero is soon to turn 29 and is established as a high-end utility player. The Yankees can still find playing time for him on most days. He’s a right-handed complement to Jazz Chisholm Jr. and Ryan McMahon at second and third base, respectively. They’re tolerating Giancarlo Stanton in right field for as long as Aaron Judge is unable to throw at game speed, but they’ll frequently kick Caballero into the outfield later in games for defensive purposes.

Yankees Notes: Judge, Volpe, Cruz

By | at

Aaron Judge has been hampered by a flexor strain in recent weeks. He first spent a minimum stint on the injured list to rest his ailing elbow, and since returning he’s been limited to exclusively DH work. Earlier this week, some questions were raised about just what shape Judge will be able to get his throwing arm back into before the end of the year. Fortunately, any concerns over Judge’s ability to throw seem to be on hold for the time being as Judge started throwing to the bases from the outfield during pregame workouts today.

The reigning AL MVP told reporters (including MLB.com’s Bryan Hoch) today that was about “checking a box” in his rehab and that he’s sticking purely to what the team’s trainers tell him to do as he works his way back into condition to resume regular duties in the outfield. Manager Aaron Boone, meanwhile, told reporters (including The Athletic’s Brendan Kuty) that while Judge “looked good” throwing to second base today, there’s still no timetable for his return to the grass in a game setting. Boone emphasized that the club feels it’s important to take Judge’s recovery process slowly in order to avoid re-injury.

That, of course, makes sense given how important Judge’s 196 wRC+ bat is to the lineup. Judge’s .218/.386/.418 (126 wRC+) slash line since returning from the IL on August 5 isn’t quite as robust as his usual otherworldly numbers, but it’s still well above average production that virtually any other hitter in the sport would be happy with. In the meantime, Giancarlo Stanton has begun playing in right field as a temporary solution to get his bat in the lineup while Judge occupies the DH slot.

Stanton’s return to the outfield isn’t the only shakeup of the Yankees lineup from the past few days. Shortstop Anthony Volpe has had a rough year on both sides of the ball, and today Boone made the decision to leave him out of the club’s starting lineup with deadline addition Jose Caballero starting at shortstop in his stead. Boone was non-committal before the game (as noted by Greg Joyce of the New York Post) about when Volpe would return to the starting lineup, but he was used as a defensive replacement in tonight’s game against the Red Sox. After a four-hit performance on August 1, Volpe has hit a paltry .121/.171/.242 in his last 19 games and was charged with an error in last night’s contest. That was enough for the Yankees to decide mix things up for at least a little while, but Volpe suggested after the game to reporters (including Kuty) that he’ll be back in the lineup for Tuesday’s game against the Nationals after sitting out tomorrow as well.

For now, it seems like this time out of the lineup is just an opportunity for Volpe to reset amid a tough stretch both at the plate and in the field. With that said, it’s at least possible that the Yankees could be looking to get Caballero a bit more playing time. Since coming over from the Rays at this year’s trade deadline, Caballero has slashed .320/.433/.600 in 31 plate appearances across 14 games with the organization. While Caballero is generally regarded as a below-average hitter overall, that recent hot streak in conjunction with his fairly well-regarded glove and impressive speed on the basepaths could be enough to earn the soon to be 29-year-old infielder some more playing time down the stretch, particularly if Volpe’s struggles continue.

On the pitching side of things, Hoch reports that the Yankees are poised to get some reinforcements tomorrow when right-hander Fernando Cruz is activated from the injured list. Cruz has been sidelined due to an oblique strain for nearly two months, but the 35-year-old had looked nothing short of excellent over the season’s first half with a 3.00 ERA, 2.48 FIP, and an eye-popping 41.2% strikeout rate in 33 innings of work prior to the injury. If Cruz looks anything like that upon his return, he should be a massive asset to a Yankees bullpen that has struggled somewhat despite the aggressive addition of reinforcements at this summer’s trade deadline. David Bednar, Devin Williams, Luke Weaver, and Camilo Doval have all taken turns in save situations but each has looked shaky of late, leaving plenty of opportunity for Cruz to fashion a key role for himself upon his return.

Yankees Notes: Weaver, Stanton, Rice, Stroman, Volpe

By | at

Yankees manager Aaron Boone provided the media (including the New York Post’s Greg Joyce and MLB.com’s Bryan Hoch) with injury updates on several players, including closer Luke Weaver.  A left hamstring strain sent Weaver to the 15-day injured list earlier this week and reports suggested Weaver would miss between 4-6 weeks, though the Yankees themselves didn’t announce a timeline.  While it is still very early in the recovery process, Weaver looks to be showing some progress, as he received a PRP injection in his hamstring and has resumed throwing in each of the last two days.

“[We] like the early stages of where he’s at and how he’s expressing to me how he feels,” Boone said of Weaver’s status.  “He’s pretty encouraged and optimistic considering the injury and the timeline with it. So hopefully he does better than that.”

While we won’t know more until (or if) the Yankees release a more concrete timeline for Weaver, it would obviously be great news for New York if the right-hander can return sooner rather than later.  Weaver has been excellent basically ever since the Yankees claimed him off waivers from the Mariners late in the 2023 season, and the reliever has become not just a high-leverage arm but a ninth-inning answer in each of the last two years.  The Yankees installed Weaver at closer when Clay Holmes ran into some struggles in 2024, and Weaver received more save situations this year in the wake of Devin Williams’ rough start.

Turning to the lineup, Giancarlo Stanton might finally be closing in on his first on-field action of 2025, as Boone suggested that “a rehab [assignment]’s in play next week.”  Stanton has been recovering from torn tendons in both elbows, and since these injuries cost him all of Spring Training, it has been a slow and gradual build as the slugger has gotten back into game shape.  His recent work at the Yankees’ spring complex in Tampa has included running drills and multiple live batting-practice sessions.

While Stanton will certainly require multiple rehab games to get him fully ramped up for a return to the majors, the exact length of his rehab stint is to be determined.  Since Stanton will be returning to a DH-only role, Boone previously said that Stanton may have something less than a standard rehab assignment, as Stanton will be focusing just on hitting rather than fielding work.  If the veteran feels his batting eye and timing are set, it could conceivably be a relatively short time in the minors for Stanton, with his health obviously also a factor.

Stanton is also expected to return to the majors in something less than a full-time capacity as the Yankees’ DH, both in order to ease him back into action and to allow Ben Rice to keep getting some time in the lineup.  Rice has cooled off significantly after a scorching start to the season, but he is still hitting .245/.330/.511 with 12 home runs over 209 plate appearances.  Most of that playing time has come as a designated hitter, but Rice has also made 10 appearances at first base and four appearances at catcher.

This will remain Rice’s positional usage once Stanton gets back, as SNY’s Andy Martino writes that the Yankees aren’t planning to use Rice as a third baseman.  Since Rice recently did some pregame fielding work at the hot corner, some speculation arose that the club might try to include Rice in its third base mix, but Martino poured cold water on that possibility.  The left-handed hitting Rice may find himself in something of a platoon with the right-handed hitting Stanton at DH, with Rice also occasionally spelling Paul Goldschmidt at first base and getting the odd game at catcher when Austin Wells or J.C. Escarra need a rest day.

Besides Stanton, Marcus Stroman may also be nearing a rehab assignment, though Boone said any decisions about Stroman’s next steps may wait until after the club sees how he fully recovers from his latest throwing session.  Stroman threw around 40 pitches over two innings of a live batting practice on Thursday, and told Boone in the immediate aftermath that his left knee was feeling good.

Inflammation in that left knee has kept Stroman from pitching in a big league game since April 11, though New York hasn’t yet moved Stroman from the 15-day IL to the 60-day IL.  It has been almost a month since Stroman’s throwing progression was shut down after more knee soreness surfaced after another live BP, so it is understandable why the Yankees are continuing to be cautious with the right-hander’s timeline after this most recent batting practice session.

It is also worth noting that Boone said Stroman will be built up as a starting pitcher, which means Stroman will be returning to his preferred role.  Early-season injuries elsewhere in New York’s rotation ensured Stroman would indeed be beginning the year as a starter once more, before his own knee issue created another hole in the starting five.  Despite the absences of Gerrit Cole, Luis Gil, and Stroman, the Yankees’ starters have remained one of the better rotations in the league, as Will Warren and especially swingman Ryan Yarbrough have been quite capable fill-ins.

Amidst all of these injuries, the Yankees seem to have dodged another bullet yesterday when scans came back negative on Anthony Volpe’s left elbow.  The shortstop was hit in the elbow by a Walker Buehler changeup in the second inning of New York’s 9-6 win over Boston, and Volpe stayed in the game until the top of the fourth.  Volpe is day-to-day for now and may be able to avoid an IL stint if the swelling and discomfort lessens in short order.

Yankees Notes: Schmidt, Volpe, Chisholm, Lombard

By | at

The Yankees were expected to send right-hander Clarke Schmidt to the mound against the Rays yesterday, but the right-hander wound up scratched from his start. MLB.com’s Bryan Hoch notes that Schmidt told reporters that he’s dealing with some soreness in his left side, but fortunately it appears to be fairly minor. Hoch adds that Schmidt even told the Yankees he would be able to take the ball yesterday, but the club opted to scratch him and push his start back to this coming Tuesday. Chris Kirschner of The Athletic notes that, per manager Aaron Boone, Schmidt underwent an MRI that came back clearn, suggesting the issue is a minor one.

That Schmidt’s soreness appears to be fairly manageable is surely a huge relief for New York. With Gerrit Cole out for the year and both Luis Gil and Marcus Stroman currently shelved with injuries of their own, losing Schmidt just three starts into his 2025 season would be a brutal blow for the Yanks. Allan Winans remains in Triple-A as a potential spot starter option, but the club’s depth is largely being used in the rotation already with Carlos Carrasco and Will Warren currently getting regular starts.

Schmidt’s 14 2/3 innings of work so far this year have hardly been inspiring, but it’s worth remembering that he’s just one year removed from posting a sterling 2.85 ERA and 3.58 FIP across 16 starts. That strong performance in 2024 suggested front-half of the rotation potential within Schmidt, and perhaps being careful with the side issue he’s currently dealing with is the best way to tap into as much of that potential as possible in a season where little is working within the club’s rotation aside from Max Fried.

Turning to the other major Yankees injury news from yesterday, Anthony Volpe had a bit of an injury scare in the eighth inning of yesterday’s game. Hoch writes that Volpe heard a “pop” in his left shoulder while attempting to field a grounder.

“It happened quick and it was scary, but after that, I felt OK and I felt like I had my strength,” Volpe said, as relayed by Hoch. “I’ve never really had anything else pop or dislocate or anything like that, so I have nothing to compare it to.”

As Hoch notes, those encouraging early comments can’t necessarily be taken as gospel just days after Volpe’s double play partner Jazz Chisholm Jr. expressed optimism that his injury was a fairly minor one just before being placed on the injured list for what figures to be a four-to-six week absence. An MRI of Chisholm’s oblique revealed three high-grade tears in the area, though fortunately the volume of tears does not appear to have significantly altered Chisholm’s timetable for return as the second baseman still expects to return in that four-to-six week time frame.

Chisholm’s injury is already testing the club’s middle infield depth and forcing a combination of Jorbit Vivas and Pablo Reyes to handle the keystone for the foreseeable future. That makes the idea of an injury for Volpe all the more concerning, but Hoch suggested that the shortstop will likely be sent for an MRI before he’s fully cleared to play again despite the fact that he finished yesterday’s game and already underwent an x-ray that revealed no structural damage. (UPDATE: Manager Aaron Boone told reporters (including Hoch) this morning that Volpe is day-to-day after the club received “good news” from his MRI exam.)

Even if the Yankees weren’t already suffering from a dearth of infield depth, losing Volpe would be a serious blow given that he’s putting up such encouraging numbers on offense. After Volpe’s first two years saw him post well-below offensive numbers buoyed by Gold Glove-caliber defense at shortstop, the 24-year-old is actually hitting an impressive .233/.326/.442 with ten doubles, five homers, and a 10.6% walk rate in 33 games. That’s good for a 121 wRC+ so far this year, and Volpe’s excellent batted ball data suggests he may actually be producing less than his underlying performance would suggest he should be. It’s an exciting potential breakout performance for the Yanks, and the fans in the Bronx are surely waiting with bated breath for their potential budding star at shortstop to return to the lineup.

All the injuries piling up for the Yankees in the rotation and around the infield likely have many fans operating with one eye on the July 31 trade deadline. There’s plenty of room for improvement on this Yankees club, but there’s at least one prospect the club is expected to keep out of trade talks this summer as they pursue back-to-back World Series appearances after losing in five games to the Dodgers in last year’s Fall Classic. According to Brendan Kuty of The Athletic, that prospect is young infielder George Lombard Jr.

As relayed by Kuty, the club does not expect Lombard to help in the majors this year but nonetheless he’s viewed by some evaluators as the club’s only “untouchable” prospect, with Kuty suggesting that it would require a “Godfather” offer to convince the Yankees to part with the young infielder. Still just 19 until next month, Lombard was the club’s first-rounder back in 2023 and is so far hitting an excellent .329/.496/.488 at the High-A level this year, with a promotion to Double-A at some point in the near future potentially in the cards.

Given that the Yankees (per Kuty) viewed Lombard as untouchable last season, when he slashed just .231/.338/.334 across two levels of A-ball, it’s hardly a shock that they aren’t inclined to trade him now that he appears to have broken out in such a substantial way. Still, with controllable aces like Pablo Lopez already seeing their names swirl in the rumor mill, refusing to part with Lombard could make it difficult for the Yankees to land a top-flight starter this summer in what figures to be a very competitive market for pitching talent.

Show all

MLB Trade Rumors is not affiliated with Major League Baseball, MLB or MLB.com

Do not Sell or Share My Personal Information

hide arrows scroll to top